144 related articles for article (PubMed ID: 8995811)
21. Proteomics of Fusobacterium nucleatum within a model developing oral microbial community.
Hendrickson EL; Wang T; Beck DA; Dickinson BC; Wright CJ; J Lamont R; Hackett M
Microbiologyopen; 2014 Oct; 3(5):729-51. PubMed ID: 25155235
[TBL] [Abstract][Full Text] [Related]
22. Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.
Karpathy SE; Qin X; Gioia J; Jiang H; Liu Y; Petrosino JF; Yerrapragada S; Fox GE; Haake SK; Weinstock GM; Highlander SK
PLoS One; 2007 Aug; 2(7):e659. PubMed ID: 17668047
[TBL] [Abstract][Full Text] [Related]
23. Detection of Fusobacterium nucleatum in two cases of empyema and lung abscess using paromomycin-vancomycin supplemented Brucella HK agar.
Nagaoka K; Yanagihara K; Morinaga Y; Kohno S
Anaerobe; 2017 Feb; 43():99-101. PubMed ID: 28034636
[TBL] [Abstract][Full Text] [Related]
24. Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity.
Gharbia SE; Shah HN; Lawson PA; Haapasalo M
Oral Microbiol Immunol; 1990 Dec; 5(6):324-7. PubMed ID: 2098710
[TBL] [Abstract][Full Text] [Related]
25. Comparative Genome Analysis of Fusobacterium nucleatum.
Ang MY; Dutta A; Wee WY; Dymock D; Paterson IC; Choo SW
Genome Biol Evol; 2016 Oct; 8(9):2928-2938. PubMed ID: 27540086
[TBL] [Abstract][Full Text] [Related]
26. Update on the taxonomy and clinical aspects of the genus fusobacterium.
Citron DM
Clin Infect Dis; 2002 Sep; 35(Suppl 1):S22-7. PubMed ID: 12173104
[TBL] [Abstract][Full Text] [Related]
27. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
28. In-vivo-induced antigenic determinants of Fusobacterium nucleatum subsp. nucleatum.
Lee HR; Rhyu IC; Kim HD; Jun HK; Min BM; Lee SH; Choi BK
Mol Oral Microbiol; 2011 Apr; 26(2):164-72. PubMed ID: 21375706
[TBL] [Abstract][Full Text] [Related]
29. Genome-Based Reclassification of Fusobacterium nucleatum Subspecies at the Species Level.
Kook JK; Park SN; Lim YK; Cho E; Jo E; Roh H; Shin Y; Paek J; Kim HS; Kim H; Shin JH; Chang YH
Curr Microbiol; 2017 Oct; 74(10):1137-1147. PubMed ID: 28687946
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of ampicillin-resistant oral Fusobacterium nucleatum.
Al-Haroni M; Skaug N; Bakken V; Cash P
Oral Microbiol Immunol; 2008 Feb; 23(1):36-42. PubMed ID: 18173796
[TBL] [Abstract][Full Text] [Related]
31. Clonal analysis by ribotyping of Fusobacterium nucleatum isolates obtained from healthy young adults with optimal plaque control.
Suchett-Kaye G; Décoret D; Barsotti O
J Periodontal Res; 1998 May; 33(4):179-86. PubMed ID: 9689613
[TBL] [Abstract][Full Text] [Related]
32. Clonality of Fusobacterium nucleatum in root canal infections.
Moraes SR; Siqueira JF; Rôças IN; Ferreira MC; Domingues RM
Oral Microbiol Immunol; 2002 Dec; 17(6):394-6. PubMed ID: 12485332
[TBL] [Abstract][Full Text] [Related]
33. Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum.
Peluso EA; Scheible M; Ton-That H; Wu C
Curr Protoc Microbiol; 2020 Jun; 57(1):e104. PubMed ID: 32539234
[TBL] [Abstract][Full Text] [Related]
34. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth.
Coppenhagen-Glazer S; Sol A; Abed J; Naor R; Zhang X; Han YW; Bachrach G
Infect Immun; 2015 Mar; 83(3):1104-13. PubMed ID: 25561710
[TBL] [Abstract][Full Text] [Related]
35. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
36. A rare case of polymicrobial chronic maxillary sinusitis due to concurrent isolation of Parvimonas micra and Fusobacterium nucleatum.
Karampatakis T; Papavasiliou A; Dimitrios Tatsis ; Paraskevopoulos K; Katsifa H
Anaerobe; 2020 Dec; 66():102284. PubMed ID: 33068731
[TBL] [Abstract][Full Text] [Related]
37. Mobile genetic elements of Fusobacterium nucleatum.
McKay TL; Ko J; Bilalis Y; DiRienzo JM
Plasmid; 1995 Jan; 33(1):15-25. PubMed ID: 7753905
[TBL] [Abstract][Full Text] [Related]
38. RNA landscape of the emerging cancer-associated microbe Fusobacterium nucleatum.
Ponath F; Tawk C; Zhu Y; Barquist L; Faber F; Vogel J
Nat Microbiol; 2021 Aug; 6(8):1007-1020. PubMed ID: 34239075
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of a human neutrophil aggregation defective mutant of Fusobacterium nucleatum.
Guo M; Reynolds H; Stinson M; De Nardin E
FEMS Immunol Med Microbiol; 2000 Mar; 27(3):241-6. PubMed ID: 10683469
[TBL] [Abstract][Full Text] [Related]
40. Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases.
Gmür R; Munson MA; Wade WG
Syst Appl Microbiol; 2006 Mar; 29(2):120-30. PubMed ID: 16464693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
